These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 16452344

  • 1. Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment.
    Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219C Team.
    Pediatrics; 2006 Feb; 117(2):273-83. PubMed ID: 16452344
    [Abstract] [Full Text] [Related]

  • 2. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [Abstract] [Full Text] [Related]

  • 3. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.
    Lindsey JC, Malee KM, Brouwers P, Hughes MD, PACTG 219C Study Team.
    Pediatrics; 2007 Mar; 119(3):e681-93. PubMed ID: 17296781
    [Abstract] [Full Text] [Related]

  • 4. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Papsdorf MP, Maan E, Cole LJ, Burdge DR.
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [Abstract] [Full Text] [Related]

  • 5. [Quality of life in HIV-infected children and adolescents under highly active antiretroviral therapy: change over time, effects of age and familial context].
    Thöni GJ, Lalande M, Bachelard G, Vidal P, Manificat S, Fédou C, Rodière M, Nicolas J.
    Arch Pediatr; 2006 Feb; 13(2):130-9. PubMed ID: 16364613
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.
    Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton SI, Yogev R, Wiznia A, Johnson GM, Krogstad P, Stanley K, Pediatric AIDS Clinical Trials Group (PACTG) 338 & 377 Study Teams.
    Pediatrics; 2005 Feb; 115(2):380-7. PubMed ID: 15687448
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
    Kline MW, Rugina S, Ilie M, Matusa RF, Schweitzer AM, Calles NR, Schwarzwald HL.
    Pediatrics; 2007 May; 119(5):e1116-20. PubMed ID: 17420261
    [Abstract] [Full Text] [Related]

  • 8. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 9. Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
    Spire B, Marcellin F, Cohen-Codar I, Flandre P, Boue F, Dellamonica P, Raffi F, Norton M, Van Philippe N, Delfraissy JF.
    Antivir Ther; 2008 Feb 15; 13(4):591-9. PubMed ID: 18672538
    [Abstract] [Full Text] [Related]

  • 10. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
    Müller AD, Myer L, Jaspan H.
    Clin Infect Dis; 2009 Jan 01; 48(1):e3-5. PubMed ID: 19025495
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP, Ghani AC, Rode RA, Bartley LM, Cowling BJ, da Silva B, Donnelly CA, van Sighem AI, Cameron DW, Danner SA, de Wolf F, Anderson RM.
    AIDS; 2006 Oct 03; 20(15):1941-50. PubMed ID: 16988515
    [Abstract] [Full Text] [Related]

  • 12. [Primary results of antiretroviral treatment among HIV/AIDS infected children in Lomé (Togo)].
    Atakouma DY, Tsolenyanu E, Gbadoe A, Gbetoglo V, Lawson-Evi K, Agbere AR, Tatagan-Agbi K, Assimadi K.
    Arch Pediatr; 2007 Oct 03; 14(10):1178-82. PubMed ID: 17531452
    [Abstract] [Full Text] [Related]

  • 13. Poor health-related quality of life and abnormal psychosocial adjustment in Italian children with perinatal HIV infection receiving highly active antiretroviral treatment.
    Bomba M, Nacinovich R, Oggiano S, Cassani M, Baushi L, Bertulli C, Longhi D, Coppini S, Parrinello G, Plebani A, Badolato R.
    AIDS Care; 2010 Jul 03; 22(7):858-65. PubMed ID: 20635250
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with health-related quality-of-life in HIV-infected Brazilians.
    Razera F, Ferreira J, Bonamigo RR.
    Int J STD AIDS; 2008 Aug 03; 19(8):519-23. PubMed ID: 18663036
    [Abstract] [Full Text] [Related]

  • 15. Quality of life in children with heart disease as perceived by children and parents.
    Uzark K, Jones K, Slusher J, Limbers CA, Burwinkle TM, Varni JW.
    Pediatrics; 2008 May 03; 121(5):e1060-7. PubMed ID: 18450848
    [Abstract] [Full Text] [Related]

  • 16. Low serum carnitine in HIV-infected children on antiretroviral treatment.
    Vilaseca MA, Artuch R, Sierra C, Pineda J, López-Vilches MA, Muñoz-Almagro C, Fortuny C.
    Eur J Clin Nutr; 2003 Oct 03; 57(10):1317-22. PubMed ID: 14506495
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up outcomes of perinatally HIV-infected adolescents: infection control but school failure.
    Souza E, Santos N, Valentini S, Silva G, Falbo A.
    J Trop Pediatr; 2010 Dec 03; 56(6):421-6. PubMed ID: 20167634
    [Abstract] [Full Text] [Related]

  • 18. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
    Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, Farley J, Malee K, PACTG 219C Team.
    Pediatrics; 2006 Dec 03; 118(6):e1745-57. PubMed ID: 17101712
    [Abstract] [Full Text] [Related]

  • 19. Antiretroviral drug therapy in HIV-infected Jamaican children.
    Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriguez B, Whorms S, Hambleton IR, Figueroa JP, Christie CD.
    West Indian Med J; 2004 Oct 03; 53(5):322-6. PubMed ID: 15675498
    [Abstract] [Full Text] [Related]

  • 20. Trauma in adolescents causes long-term marked deficits in quality of life: adolescent children do not recover preinjury quality of life or function up to two years postinjury compared to national norms.
    Holbrook TL, Hoyt DB, Coimbra R, Potenza B, Sise MJ, Sack DI, Anderson JP.
    J Trauma; 2007 Mar 03; 62(3):577-83; discussion 583. PubMed ID: 17414331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.